Clinical trials
Phase 3 Erythema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 3 |
| Galderma R&D | 3 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Faes Farma, S.A. | 1 |
| Goldman, Butterwick, Fitzpatrick and Groff | 1 |
| Memorial University of Newfoundland | 1 |
| Padagis LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Erythema | 11 |
| Rosacea | 6 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Erythema Multiforme | 1 |
| Fever | 1 |
| Hypersensitivity, Immediate | 1 |
| Infections | 1 |
| Leukocytosis | 1 |
| Sepsis | 1 |
| Skin Diseases, Vascular | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.